CBSA Hosts Annual Medical Device Symposium
By: Colorado BioScience Association Date: 04/17/2023
Innovative medical technologies are transforming patient care around the world and MedTech in Colorado is growing strong with more than 2,200 devices in development or distribution. Many of the most promising innovations are being developed at the intersection of devices, drugs, diagnostics and digital health.
On April 13, 2023, Colorado BioScience Association held its Annual Medical Device Symposium, where attendees joined CBSA, innovators, and medical technology community leaders at the Westin Westminster to discover emerging and cutting-edge trends in medical breakthroughs, gain insights on the pulse of the industry as MedTech adjusts to a new post-pandemic landscape, and take an in-depth look at public policy shaping the U.S. MedTech sector.
Speakers and panelists provided their perspectives on developing and launching new products and the convergence of digital health and medical technology in the state during the symposium.
Our keynote Speaker, Antionette Gawin, President & CEO of Terumo Blood and Cell Technologies, kicked off the event with a conversation about leadership, purpose, and Terumo’s journey to creating global accessibility to critical medical technology. She highlighted the deep importance of accessibility to medical technologies in general, as well, noting that making innovations accessible and adaptable in order to reach the patients who need them is a key component to a fulfilling and impactful career in MedTech.
Federal and State Policy Update + EY’s Pulse of the Industry Medical Technology Report
Following our keynote, Roxy Kozyckyj, State Government & Regional Affairs at AdvaMed and Amy Berenbaum Goodman, J.D., MBE, CBSA Vice President and Counsel for Policy + Advocacy, provided updates on state and federal policies and issues affecting the life sciences ecosystem, including sterilization, biomarker testing, data privacy, and others.
John Heinbigner, Partner at EY, spoke on industry trends and explored EY’s Pulse of the Industry Medical Technology Report, which offered insight on public MedTech revenue growth rates, MedTech stocks, private venture capital in relation to MedTech, M&A activity in the MedTech sector, and more.
Panel Discussion: Intersections in Medical Device Innovation
Next, Tony Caldwell, J.D., Partner at Snell & Wilmer, led our panel discussion, Intersections in Medical Device Innovation.
The panel consisted of prominent leaders in MedTech Frank Chan, President of Patient Monitoring at Medtronic; James Mault, M.D., FACS, CEO & Chairman at BioIntelliSense; Natasha Bond, President of ERI Group; and William Jaworski, Sales Director at Mikron Corporation Denver. Kimberly Muller, J.D., Executive Director at CU Innovations, University of Colorado Anschutz Medical Campus, was unable to attend.
The panel engaged in conversation about hospital-to-home technology, as well as MedTech industry growth, opportunities, and challenges. They also touched on the future of MedTech and the reasoning behind Colorado’s popularity for those looking to make an impact on the industry.
Happy Hour + Networking
Immediately following programming, attendees were invited to visit exhibitor booths, and to engage in a happy hour networking opportunity, sponsored by CSA Group .
Thank you to our exhibitors, Fisher Scientific, LeafTech Consulting, AdvaMed, BoulderIQ, RedDrop DX, CSA Group, Mikron Automation, and Terumo Blood & Cell Technologies, for showcasing your life changing and saving work, and to our emcee, Daniel Wittenberg, J.D., Co-Chair of the Life Science & MedTech Industry Group at Snell & Wilmer.
Thank you to CSA Group for hosting our networking happy hour – CBSA is grateful for this opportunity to connect our community.